Stemtech Corporation completes merger with Seacret Direct / VIÁGO, aiming to double revenue through strategic integration

Stemtech Corporation (OTCQB:STEK) has successfully executed a merger agreement with Seacret Direct / VIÁGO, progressing their plan to double revenue and establish a global leadership position in defining the future of lifestyle, health, and longevity. The merger creates a vertically integrated powerhouse poised to lead and redefine health, longevity, and lifestyle, offering smarter, more comprehensive solutions to improving quality of daily life. The consolidated revenue forecast for 2025 is expected to double or more with planned cost synergies, delivering positive bottom-line results through optimization and existing growth trajectories alone.